Literature DB >> 17688499

Accounting for variability in sample size estimation with applications to nonadherence and estimation of variance and effect size.

Michael P Fay1, M Elizabeth Halloran, Dean A Follmann.   

Abstract

We consider sample size calculations for testing differences in means between two samples and allowing for different variances in the two groups. Typically, the power functions depend on the sample size and a set of parameters assumed known, and the sample size needed to obtain a prespecified power is calculated. Here, we account for two sources of variability: we allow the sample size in the power function to be a stochastic variable, and we consider estimating the parameters from preliminary data. An example of the first source of variability is nonadherence (noncompliance). We assume that the proportion of subjects who will adhere to their treatment regimen is not known before the study, but that the proportion is a stochastic variable with a known distribution. Under this assumption, we develop simple closed form sample size calculations based on asymptotic normality. The second source of variability is in parameter estimates that are estimated from prior data. For example, we account for variability in estimating the variance of the normal response from existing data which are assumed to have the same variance as the study for which we are calculating the sample size. We show that we can account for the variability of the variance estimate by simply using a slightly larger nominal power in the usual sample size calculation, which we call the calibrated power. We show that the calculation of the calibrated power depends only on the sample size of the existing data, and we give a table of calibrated power by sample size. Further, we consider the calculation of the sample size in the rarer situation where we account for the variability in estimating the standardized effect size from some existing data. This latter situation, as well as several of the previous ones, is motivated by sample size calculations for a Phase II trial of a malaria vaccine candidate.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17688499     DOI: 10.1111/j.1541-0420.2006.00703.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  7 in total

1.  An alternative property for evaluating sample size for normal data using preliminary data.

Authors:  Michael P Fay
Journal:  Clin Trials       Date:  2013       Impact factor: 2.486

2.  Power for studies with random group sizes.

Authors:  Walter T Ambrosius; Jonathan D Mahnken
Journal:  Stat Med       Date:  2010-05-10       Impact factor: 2.373

3.  Design of the value of imaging in enhancing the wellness of your heart (VIEW) trial and the impact of uncertainty on power.

Authors:  Walter T Ambrosius; Tamar S Polonsky; Philip Greenland; David C Goff; Letitia H Perdue; Stephen P Fortmann; Karen L Margolis; Nicholas M Pajewski
Journal:  Clin Trials       Date:  2012-02-14       Impact factor: 2.486

4.  A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in Mali.

Authors:  Issaka Sagara; Alassane Dicko; Ruth D Ellis; Michael P Fay; Sory I Diawara; Mahamadoun H Assadou; Mahamadou S Sissoko; Mamady Kone; Abdoulbaki I Diallo; Renion Saye; Merepen A Guindo; Ousmane Kante; Mohamed B Niambele; Kazutoyo Miura; Gregory E D Mullen; Mark Pierce; Laura B Martin; Amagana Dolo; Dapa A Diallo; Ogobara K Doumbo; Louis H Miller; Allan Saul
Journal:  Vaccine       Date:  2009-03-25       Impact factor: 3.641

5.  Assess the effects of culturally relevant intervention on breast cancer knowledge, beliefs, and mammography use among Korean American women.

Authors:  Jin Hee Kim; Usha Menon; Edward Wang; Laura Szalacha
Journal:  J Immigr Minor Health       Date:  2009-04-17

6.  Effect of a Multicomponent Home-Based Physical Therapy Intervention on Ambulation After Hip Fracture in Older Adults: The CAP Randomized Clinical Trial.

Authors:  Jay Magaziner; Kathleen K Mangione; Denise Orwig; Mona Baumgarten; Laurence Magder; Michael Terrin; Richard H Fortinsky; Ann L Gruber-Baldini; Brock A Beamer; Anna N A Tosteson; Anne M Kenny; Michelle Shardell; Ellen F Binder; Kenneth Koval; Barbara Resnick; Ram Miller; Sandra Forman; Ruth McBride; Rebecca L Craik
Journal:  JAMA       Date:  2019-09-10       Impact factor: 56.272

7.  Calculating sample size for studies with expected all-or-none nonadherence and selection bias.

Authors:  Michelle D Shardell; Samer S El-Kamary
Journal:  Biometrics       Date:  2009-06       Impact factor: 2.571

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.